Patents by Inventor Daniela WILLEN

Daniela WILLEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Opthalmic compositions comprising F6H8
    Patent number: 11896559
    Abstract: The present disclosure provides methods of treatment using ophthalmic compositions comprising semifluorinated alkanes for keratoconjunctivitis sicca and/or Meibomian gland dysfunction, which methods provide for the enrichment of an ophthalmic tissue in the semifluorinated alkane, and optionally methods of delayed release of the semifluorinated alkane from the enriched ophthalmic tissue to the surface of the cornea and/or conjunctiva, and/or to the Meibomian gland.
    Type: Grant
    Filed: October 3, 2018
    Date of Patent: February 13, 2024
    Assignee: NOVALIQ GMBH
    Inventors: Bernhard Günther, Frank Löscher, Hartmut Voss, Sonja Krösser, Kirsten Eickhoff, Daniela Willen, Markus Beier, Thomas Schlüter
  • OPHTHALMIC COMPOSITIONS FOR TREATMENT OF OCULAR SURFACE DAMAGE AND SYMPTOMS OF DRYNESS
    Publication number: 20210346313
    Abstract: The present disclosure provides methods of treatment using ophthalmic compositions, comprising 1-perfluorohexyloctane, which are useful in the treatment of ocular surface damage of the cornea and/or symptoms of dryness.
    Type: Application
    Filed: September 20, 2019
    Publication date: November 11, 2021
    Inventors: Markus BEIER, Daniela WILLEN, Sonja KRÖSSER, Thomas SCHLÜTER
  • OPTHALMIC COMPOSITIONS COMPRISING F6H8
    Publication number: 20200268682
    Abstract: The present disclosure provides methods of treatment using ophthalmic compositions comprising semifluorinated alkanes for keratoconjunctivitis sicca and/or Meibomian gland dysfunction, which methods provide for the enrichment of an ophthalmic tissue in the semifluorinated alkane, and optionally methods of delayed release of the semifluorinated alkane from the enriched ophthalmic tissue to the surface of the cornea and/or conjunctiva, and/or to the Meibomian gland.
    Type: Application
    Filed: October 3, 2018
    Publication date: August 27, 2020
    Inventors: Bernhard GÜNTHER, Frank LÖSCHER, Hartmut VOSS, Sonja KRÖSSER, Kirsten EICKHOFF, Daniela WILLEN, Markus BEIER, Thomas SCHLÜTER